• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Pathology and Laboratory Medicine
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Pathology and Laboratory Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy

    Thumbnail
    View/ Open
    Article (702.6Kb)

    Show full item record
    Author
    Devi, Gayathri R.; Finetti, Pascal; Morse, Michael A.; Lee, Seayoung; de Nonneville, Alexandre; Van Laere, Steven; Troy, Jesse; Geradts, Joseph; McCall, Shannon; Bertucci, Francois
    URI
    http://hdl.handle.net/10342/10787
    Subject
     anthracycline; apoptosis; cell death 
    Date
    2021-06-04
    Citation:
    APA:
    Devi, Gayathri R., & Finetti, Pascal, & Morse, Michael A., & Lee, Seayoung, & de Nonneville, Alexandre, & Van Laere, Steven, & Troy, Jesse, & Geradts, Joseph, & McCall, Shannon, & Bertucci, Francois. (June 2021). Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. , (), - . Retrieved from http://hdl.handle.net/10342/10787

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Devi, Gayathri R., and Finetti, Pascal, and Morse, Michael A., and Lee, Seayoung, and de Nonneville, Alexandre, and Van Laere, Steven, and Troy, Jesse, and Geradts, Joseph, and McCall, Shannon, and Bertucci, Francois. "Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy". . . (), June 2021. February 02, 2023. http://hdl.handle.net/10342/10787.
    Chicago:
    Devi, Gayathri R. and Finetti, Pascal and Morse, Michael A. and Lee, Seayoung and de Nonneville, Alexandre and Van Laere, Steven and Troy, Jesse and Geradts, Joseph and McCall, Shannon and Bertucci, Francois, "Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy," , no. (June 2021), http://hdl.handle.net/10342/10787 (accessed February 02, 2023).
    AMA:
    Devi, Gayathri R., Finetti, Pascal, Morse, Michael A., Lee, Seayoung, de Nonneville, Alexandre, Van Laere, Steven, Troy, Jesse, Geradts, Joseph, McCall, Shannon, Bertucci, Francois. Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. . June 2021; (): . http://hdl.handle.net/10342/10787. Accessed February 02, 2023.
    Collections
    • Pathology and Laboratory Medicine

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback